Ecog-Acrin Ea2182- A Randomized Phase II Study Of De-Intensified Chemoradiation For Early- Stage Anal Squamous Cell Carcinoma
Posted Date: Jul 8, 2020
- Investigator: Jordan Kharofa
- Specialties: Cancer, Oncology
- Type of Study: Drug
The goal of this study is To determine whether de-intensified chemoradiation for early stage SCCA is able to maintain excellent 2-year disease control of 85% or higher while improving anorectal HRQL, compared to standard-dose CRT, as measured by the change in the FIQoL instrument coping/behavior domain from baseline to 1 year
Criteria:
To Be Eligible: Must Have T1-2N0m0 Invasive Anal Canal Or Anal Margin Squamous Cell Carcinoma, Ecog 0-2, No Prior Potentially Curative Surgery For Anus Carcinoma, No Significant Cardiovascular Disease, No Other Malignancy Within 3 Years
Keywords:
Anal Carcinoma
For More Information:
Uc Cancer Center
513-584-7698
cancer@uchealth.com